about
Chlamydia trachomatis Infection in Pregnancy: The Global Challenge of Preventing Adverse Pregnancy and Infant Outcomes in Sub-Saharan Africa and AsiaInnate immunity is sufficient for the clearance ofChlamydia trachomatisfrom the female mouse genital tractGenetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropismConsiderations for the rational design of a Chlamydia vaccineChlamydia trachomatis neither exerts deleterious effects on spermatozoa nor impairs male fertility.Infectivity of urogenital Chlamydia trachomatis plasmid-deficient, CT135-null, and double-deficient strains in female miceChlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigsSeroprevalence of antibodies against Pkn1, a novel potential immunogen, in Chlamydia trachomatis-infected Macaca nemestrina and human patients.Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs.A re-evaluation of the role of B cells in protective immunity to Chlamydia infectionCost-effectiveness of Chlamydia vaccination programs for young womenBioinformatic Analysis of Chlamydia trachomatis Polymorphic Membrane Proteins PmpE, PmpF, PmpG and PmpH as Potential Vaccine Antigens.A Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C.Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in miceGuinea pig genital tract lipidome reveals in vivo and in vitro regulation of phosphatidylcholine 16:0/18:1 and contribution to Chlamydia trachomatis serovar D infectivity.Chlamydial Protease-Like Activity Factor and Type III Secreted Effectors Cooperate in Inhibition of p65 Nuclear Translocation.Towards a safe and effective chlamydial vaccine: lessons from the eyeUpdate on Chlamydia trachomatis Vaccinology.The Predominant CD4+ Th1 Cytokine Elicited to Chlamydia trachomatis Infection in Women Is Tumor Necrosis Factor Alpha and Not Interferon Gamma.Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.Chlamydia muridarum infection-induced destruction of male germ cells and sertoli cells is partially prevented by Chlamydia major outer membrane protein-specific immune CD4 cells.Identification of linear B-cell epitopes within Tarp of Chlamydia trachomatis.Whole-Exome Sequencing to Identify Novel Biological Pathways Associated With Infertility After Pelvic Inflammatory Disease.Distribution of Chlamydia Trachomatis Genotypes in Infective Diseases of the Female Lower Genital Tract.The M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune
P2860
Q26752829-F91AF249-C16B-4013-B8BD-8904B48D5931Q29032025-7B144A7F-D1CA-449D-A2F2-F6B75DC0B3E1Q33565893-E19FF2B7-CF2A-463E-BFAA-EC6AE317A41FQ33601324-704C9F02-3A81-4CA3-9C00-7CEB9A1CE097Q33683122-9001CD90-4E9C-46CE-95CF-536369927290Q33723211-7EBAAC37-3CAB-4F22-B313-CF00DD05296EQ33740057-61AAC18E-A187-4F7E-B0D7-4F516BC824A6Q33861740-C780BFD7-6621-4D08-82DD-4240EC799B69Q34680475-399EC685-70C1-49D1-9F7B-BDEC95C7F4E8Q35471373-0C7A866D-799C-4963-897A-8D6D725996B8Q35673354-D03408C0-CDC0-4041-857D-9DC2A95BB0AFQ35679647-2787DE29-0ED9-498F-8067-B7DE319F5313Q36135698-9788881A-0FFB-4F05-B620-2F75D125CC85Q37140167-53FDD80F-9126-412B-992E-20C15D573CBEQ37255052-37A727EE-EA5B-4433-8A3F-2D9EFB35DB04Q37292262-0DC01272-D67E-4F95-8542-581101CA549EQ37709748-D76D81FF-3D63-4C8A-AE1A-76B80A389A80Q37834874-B31E06B8-F2EC-473B-B8BF-D0AA622D384AQ37835132-8CA357BB-D392-4729-B50A-25EC4A6A58CCQ37837221-2BA2A574-342E-413F-9F9F-44D452D24D8EQ37842770-17A9107A-BD2C-4722-B677-E5B102B92098Q37843064-39B56A20-4B32-4DE3-95D8-3E9A157C4C3BQ40431321-A9F55D09-D26F-434A-A4C7-D021AB2708C7Q42364246-6753CA6D-F4F0-4E1F-A9A1-C99A7FD915D8Q58122056-03FAC030-B355-4799-9106-AC042775B994
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chlamydia trachomatis control requires a vaccine.
@ast
Chlamydia trachomatis control requires a vaccine.
@en
Chlamydia trachomatis control requires a vaccine.
@nl
type
label
Chlamydia trachomatis control requires a vaccine.
@ast
Chlamydia trachomatis control requires a vaccine.
@en
Chlamydia trachomatis control requires a vaccine.
@nl
prefLabel
Chlamydia trachomatis control requires a vaccine.
@ast
Chlamydia trachomatis control requires a vaccine.
@en
Chlamydia trachomatis control requires a vaccine.
@nl
P2860
P1433
P1476
Chlamydia trachomatis control requires a vaccine.
@en
P2093
Robert C Brunham
P2860
P304
P356
10.1016/J.VACCINE.2013.01.024
P407
P577
2013-01-29T00:00:00Z